Drug Discovery Chemistry

2018 Archived Content

Save the Date! Next Year's Event will take Place at the San Diego Convention Center from April 8-12, 2019

2019 Plenary Keynotes

Chemical Biology of Proteostasis

Jack Taunton, PhD, Professor, Department of Cellular and Molecular Pharmacology, University of California San Francisco

New Ways of Targeting K-Ras

Frank McCormick, PhD, Professor, HDF Comprehensive Cancer Center, University of California San Francisco

APRIL 3-4, 2018

Protein-Protein Interactions

Inflammation and Autoimmune Inhibitors

Kinase Inhibitor Chemistry

GPCR-Targeted
Drug Design

Fragment-Based
Drug Discovery

APRIL 4-5, 2018

Ubiquitin Proteasome System Inhibitors

Small Molecules for Cancer Immunotherapy

Macrocyclics & Constrained Peptides

Targeting Complex Membrane Proteins

APRIL 6, 2018

Biophysical Approaches for Drug Discovery

Lead Optimization for Drug Metabolism & Safety

Blood-Brain
Penetrant Inhibitors

About the Event

Cambridge Healthtech Institute's 13th Annual Drug Discovery Chemistry is a dynamic conference for medicinal chemists working in pharma and biotech. Focused on discovery and optimization challenges of small molecule drug candidates, this event provides many exciting opportunities for scientists to create a unique program to hear presentations most suited to one's personal interests by going back and forth among concurrent meeting tracks.

New for 2018 is expanded coverage of Small Molecules for Cancer Immunotherapy, plus new coverage of Ubiquitin Proteasome System Inhibitors, Targeting Complex Membrane Proteins, as well as Lead Optimization for Drug Safety.

Event Features